During the past decade, Strasbourg Oncologie Libérale conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Strasbourg Oncologie Libérale" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Ipsen" with 2 trials sponsored, "The Lymphoma Academic Research Organisation" with 2 trials sponsored, "UNICANCER" with 2 trials sponsored and "Centre Leon Berard" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Strasbourg Oncologie Libérale" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Centre Henri Becquerel" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Ipsen" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Strasbourg Oncologie Libérale" are "Breast Cancer" (3 trials), "Acute Myeloid Leukemia" (1 trials), "Chemotherapy-induced Neutropenia" (1 trials), "Diffuse Large B Cell Lymphoma" (1 trials) and "Diffuse Large B Cell Lymphoma CD20 Positive" (1 trials). Many other conditions were trialed in "Strasbourg Oncologie Libérale" in a lesser frequency.

Most popular intervention types in "Strasbourg Oncologie Libérale" are "Drug" (11 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Lenalidomide" (2 trials), "Rituximab" (2 trials), "5Fluorouracil" (1 trials) and "AFATINIB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Strasbourg Oncologie Libérale" are 9 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Strasbourg Oncologie Libérale". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Strasbourg Oncologie Libérale, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Strasbourg Oncologie Libérale, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Strasbourg Oncologie Libérale has several departments that took part in Clinical trials: "Strasbourg Oncologie Médicale" - 2 trials